Committed to Medical Innovations

Every day—in research labs across eastern Massachusetts—investigators, doctors and nurses at Partners HealthCare are working to discover new treatment options, medical devices and technology to improve the lives and outcomes of patients. Partners HealthCare Innovation works directly with researchers at Brigham and Women’s Hospital, Massachusetts General Hospital, McLean Hospital and Spaulding Hospital to commercialize their innovations. It is our mission to enable commercialization through the best route for a given technology, and ensure that technologies can benefit patients.

Portfolio News

Editas Medicine pricing shares at $16 for year’s first IPO: reports

Editas Medicine Inc. EDIT, +0.00% priced shares for its initial public offering at the low end of the range, according to media reports late Tuesday, for what will be 2016’s first IPO. Editas will price 5.9 million shares at $16 a share, at the low end of its $16 to $18 range, to raise $94.4…

Read More


Special Announcements

Innovation Discovery Grant

PARTNERS INNOVATION DEVELOPMENT GRANTS PROGRAMProgram Guidelines – 2016 Program Cycle BACKGROUND AND PURPOSEThe Innovation Discovery Grants (IDG) program aims to enhance the commercial outcomes of the Partners HealthCare community and to increase its innovative potential. It is designed to stimulate new inventive concepts, identify areas of commercially significant scientific strength, and accelerate commercialization of Partners…

Read More


We are pleased to announce the 2016 World Medical Innovation Forum. This annual gathering in Boston of more than 1,000 top innovation decision makers will focus on cancer and be held on April 25–27, 2016.

Click here for additional details about this exciting new event.


Newsletters and Other Recent Publications

View here